Literature DB >> 21472610

Sequence elucidation of an unknown cyclic peptide of high doping potential by ETD and CID tandem mass spectrometry.

Fuyu Guan1, Cornelius E Uboh, Lawrence R Soma, Jeffrey Rudy.   

Abstract

Identification of an unknown substance without any information remains a daunting challenge despite advances in chemistry and mass spectrometry. However, an unknown cyclic peptide in a sample with very limited volume seized at a Pennsylvania racetrack has been successfully identified. The unknown sample was determined by accurate mass measurements to contain a small unknown peptide as the major component. Collision-induced dissociation (CID) of the unknown peptide revealed the presence of Lys (not Gln, by accurate mass), Phe, and Arg residues, and absence of any y-type product ion. The latter, together with the tryptic digestion results of the unusual deamidation and absence of any tryptic cleavage, suggests a cyclic structure for the peptide. Electron-transfer dissociation (ETD) of the unknown peptide indicated the presence of Gln (not Lys, by the unusual deamidation), Phe, and Arg residues and their connectivity. After all the results were pieced together, a cyclic tetrapeptide, cyclo[Arg-Lys-N(C(6)H(9))Gln-Phe], is proposed for the unknown peptide. Observations of different amino acid residues from CID and ETD experiments for the peptide were interpreted by a fragmentation pathway proposed, as was preferential CID loss of a Lys residue from the peptide. ETD was used for the first time in sequencing of a cyclic peptide; product ions resulting from ETD of the peptide identified were categorized into two types and named pseudo-b and pseudo-z ions that are important for sequencing of cyclic peptides. The ETD product ions were interpreted by fragmentation pathways proposed. Additionally, multi-stage CID mass spectrometry cannot provide complete sequence information for cyclic peptides containing adjacent Arg and Lys residues. The identified cyclic peptide has not been documented in the literature, its pharmacological effects are unknown, but it might be a "designer" drug with athletic performance-enhancing effects. © American Society for Mass Spectrometry, 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472610     DOI: 10.1007/s13361-011-0080-5

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  28 in total

1.  Mass spectrometric fragmentation of cyclic peptides belonging to the polymyxin and colistin antibiotics studied by ion trap and quadrupole/orthogonal-acceleration time-of-flight technology.

Authors:  Cindy Govaerts; Jef Rozenski; Jennifer Orwa; Eugène Roets; Ann Van Schepdael; Jos Hoogmartens
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

2.  Dehydration versus deamination of N-terminal glutamine in collision-induced dissociation of protonated peptides.

Authors:  Pedatsur Neta; Quan-Long Pu; Lisa Kilpatrick; Xiaoyu Yang; Stephen E Stein
Journal:  J Am Soc Mass Spectrom       Date:  2006-09-26       Impact factor: 3.109

3.  Consecutive cyclic pentapeptide modules form short alpha-helices that are very stable to water and denaturants.

Authors:  Nicholas E Shepherd; Giovanni Abbenante; David P Fairlie
Journal:  Angew Chem Int Ed Engl       Date:  2004-05-10       Impact factor: 15.336

Review 4.  De novo sequencing of peptides by MS/MS.

Authors:  Joerg Seidler; Nico Zinn; Martin E Boehm; Wolf D Lehmann
Journal:  Proteomics       Date:  2010-02       Impact factor: 3.984

5.  Tertiary structure is a principal determinant to protein deamidation.

Authors:  A A Kossiakoff
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

6.  Fast atom bombardment combined with tandem mass spectrometry for the determination of cyclic peptides.

Authors:  K B Tomer; F W Crow; M L Gross; K D Kopple
Journal:  Anal Chem       Date:  1984-05       Impact factor: 6.986

7.  Multistep tandem mass spectrometry for sequencing cyclic peptides in an ion-trap mass spectrometer.

Authors:  L C Ngoka; M L Gross
Journal:  J Am Soc Mass Spectrom       Date:  1999-08       Impact factor: 3.109

8.  Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.

Authors:  A Friedler; N Zakai; O Karni; Y C Broder; L Baraz; M Kotler; A Loyter; C Gilon
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

9.  Profiling of cyclic hexadepsipeptides roseotoxins synthesized in vitro and in vivo: a combined tandem mass spectrometry and quantum chemical study.

Authors:  Alexandr Jegorov; Béla Paizs; Martin Zabka; Marek Kuzma; Vladimír Havlícek; Anastassios E Giannakopulos; Peter J Derrick
Journal:  Eur J Mass Spectrom (Chichester)       Date:  2003       Impact factor: 1.067

10.  Bioactive peptidic analogues and cyclostereoisomers of the minimal antinociceptive histogranin fragment-(7-10).

Authors:  Hoang-Thanh Le; Irma B Lemaire; Annie-Kim Gilbert; François Jolicoeur; Simon Lemaire
Journal:  J Med Chem       Date:  2003-07-03       Impact factor: 7.446

View more
  2 in total

1.  Gas-phase ion isomer analysis reveals the mechanism of peptide sequence scrambling.

Authors:  Chenxi Jia; Zhe Wu; Christopher B Lietz; Zhidan Liang; Qiang Cui; Lingjun Li
Journal:  Anal Chem       Date:  2013-12-17       Impact factor: 6.986

2.  Identification and Structural Characterization of Naturally-Occurring Broad-Spectrum Cyclic Antibiotics Isolated from Paenibacillus.

Authors:  Ann M Knolhoff; Jie Zheng; Melinda A McFarland; Yan Luo; John H Callahan; Eric W Brown; Timothy R Croley
Journal:  J Am Soc Mass Spectrom       Date:  2015-08-07       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.